IAS 10 para 17, date of authorisation of financial statements for issue

Roche Holding Ltd – Annual report – 31 December 2022

Industry: pharmaceuticals

Basis of preparation (extract)

The consolidated financial statements (hereafter ‘the Annual Financial Statements’) of the Roche Group have been prepared in accordance with International Financial Reporting Standards (IFRS) and comply with Swiss law. They have been prepared using the historical cost convention except for items that are required to be accounted for at fair value. They were approved for issue by the Board of Directors on 31 January 2023 and are subject to approval by the Annual General Meeting of shareholders on 14 March 2023.